UCLA Med School Scandal: DOJ Uncovers Racial Bias

UCLA campus with banners displaying '#1' and 'UCLA' near a historic building

UCLA’s elite medical school secretly favored Black and Hispanic applicants over higher-scoring whites and Asians, defying the Supreme Court—now the DOJ vows to dismantle this racial favoritism.

Story Highlights

DOJ’s year-long probe uncovers UCLA David Geffen School of Medicine’s intentional race-based discrimination in 2023-2025 admissions cycles.
Evidence reveals lower GPAs and MCATs for favored groups, internal memos pushing BIPOC quotas, and shaming tactics on staff.
Violates 2023 Supreme Court SFFA v. Harvard ruling and California’s Prop 209 ban on race preferences.
Trump DOJ, led by Harmeet K. Dhillon, eyes lawsuits and federal funding cuts to enforce merit over demographics.
First major post-SFFA enforcement against a top med school, signaling nationwide crackdown on DEI excesses.

DOJ Uncovers Racial Discrimination at UCLA Med School

U.S. Department of Justice investigators concluded UCLA’s David Geffen School of Medicine discriminated against white and Asian American applicants. Admissions staff favored Black and Hispanic candidates despite lower average GPAs and MCAT scores. A 7-page findings letter released May 6, 2026, details violations during 2023-2025 cycles. Internal emails and memos prioritized “BIPOC” representation. DOJ joined a January 2026 private lawsuit by Do No Harm and Students for Fair Admissions, expanding the probe.

Supreme Court Ruling Ignored Despite Clear Ban

Supreme Court’s 2023 Students for Fair Admissions v. Harvard decision prohibited race as a “plus factor” in admissions. UCLA DGSOM circumvented this through essays, a “PREview Exam” revealing race, and training materials assuming same-race doctors improve outcomes. DOJ deems these practices illegal under Title VI, which bars race discrimination in federally funded programs. California’s Proposition 209 has banned such preferences since 1996, yet DGSOM persisted post-ruling.

Key Evidence from Internal Documents

Admissions Associate Dean Jennifer Lucero pressured staff to meet diversity goals, using shaming tactics for insufficient BIPOC admits. DOJ data shows 2024 Black admits averaged 3.72 GPA versus 3.84 for Asians and 3.83 for whites. A “guiding principles” memo enforced racial quotas. These facts align with common sense: merit ensures competent doctors, not skin color. Pro-DEI claims of better patient outcomes lack evidence, prioritizing ideology over safety.

Stakeholders Clash in High-Stakes Battle

Harmeet K. Dhillon, DOJ Civil Rights Assistant Attorney General, calls the practices “illegal and anti-American racism.” U.S. Attorney Bill Essayli labels DEI policies unconstitutional. Plaintiffs, including a rejected white applicant, seek merit-based access. UCLA remains silent amid pending litigation. Affected white and Asian applicants lost spots to lower-qualified peers, raising patient care risks from diminished standards.

UCLA Med School Illegally Using Race In Admissions: DOJ https://t.co/oZEW8lwV4l

— zerohedge (@zerohedge) May 8, 2026

Impending Consequences and Broader Reforms

DOJ weighs lawsuits and Title VI funding cuts, endangering UCLA’s $100 million-plus federal grants. Short-term fallout includes reputational harm and recruitment struggles for top talent. Long-term, this sets precedent chilling DEI nationwide, boosting white and Asian enrollment via strict merit. Similar probes target UC San Diego, Stanford, and Ohio State med schools. Trump administration’s push restores fairness, countering reverse discrimination.